Key facts
- This page summarizes Naomi Rozenfeld's Form 3 filing for Brainsway Ltd. (BWAY).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Mar 2026, 16:04.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
This figure includes 25,000 unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, with 6,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030.
Footnote F3
Stock options were granted on December 22, 2025, with options to purchase 18,750 ordinary shares vesting on December 22, 2026 and the remaining options vesting in equal quarterly installments until December 22, 2029.
Footnote F4
The exercise price is NIS 30.74 per share.